Advertisement

The Use of Valproate and Oxcarbazepine in Affective Disorders

  • H. M. Emrich
  • M. Dose
  • R. Günther
  • D. von Zerssen

Abstract

Lithium prophylaxis which, undoubtedly, represents a great breakthrough in the pharmacopsychiatry of affective disorders contains two disadvantages:
  • 1st There is a sizable number of patients not responding to this therapy, and

  • 2nd in some patients there is a great number of side effects leading to non-compliance or discontinuation of lithium prophylaxis.

Keywords

Affective Disorder Affective Case Lithium Prophylaxis Psychopathological Evaluation Opiate Antagonist Naloxone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ballenger, J.C., and Post, R.M., 1980, Carbamazepine in manic-depressive illness: A new treatment,Am. J. Psychiatry, 137: 782–790.PubMedGoogle Scholar
  2. Bernasconi, R., 1982, The GABA Hypothesis of affective illness: in fluence of clinically effective antimanic drugs on GABA turnover,in Basic Mechanisms in the Action of Lithium, H.M. Emrich, J.B. Aldenhoff, andH.D. Lux, eds., Excerpta Medica, Amsterdam, pp. 183–192.Google Scholar
  3. Chouinard, G., Young, S.N., and Annable, L., 1983, Antimanic effect of clonazepam,Biol. Psychiat., 18: 451–466.PubMedGoogle Scholar
  4. Emrich, H.M., 1982, Prophylactic therapies in affective disorders: mode of action from a clinical point of view,in Basic Mechanisms in the Action of Lithium, H.M. Emrich, J.B. Aldenhoff and H.D. Lux, eds., Excerpta Medica, Amsterdam, pp 202–214.Google Scholar
  5. Emrich, H.M., Cording, C., Pirée, S., Kölling, A., v. Zerssen, D., and Herz, A., 1977, Indication of an antipsychotic action of the opiate antagonist naloxone. Pharmakopsychiat., 10: 265–270.CrossRefGoogle Scholar
  6. Emrich, H.M., v. Zerssen, D., Möller, H.-J., Kissling, W., Cording, C., Schietsch, H.J., and Riedel, E., 1979, Action of propranolol in mania: Comparison of effects of the d- and the 1-stereoisomerPharmakopsychiat., 12: 295–304.CrossRefGoogle Scholar
  7. Emrich H.M., v. Zerssen, D., Kissling, W., Möller, H.-J. and Windorfer, A., 1980, Effect of sodiumvalporate on mania. The GABA-hypothesis of affective disorders,Arch. Psychiay. Nervenkr 229: 1–16.CrossRefGoogle Scholar
  8. Emrich, H.M., vZerssen, D., Kissling, W., and Möller, H.-J., 1981, Therapeutic effect of valproate in mania, Am. J. Psychiatry, 138: 256.PubMedGoogle Scholar
  9. Emrich, H.M., Altmann, H., Dose, M., and von Zerssen, D., 1983, Thera peutic effects of GABA-ergic drugs in affective disorders: A preliminary report,Pharmacol., Biochem. Behav. (in press).Google Scholar
  10. Hendler, N.H., 1978, Spironolactone prophylaxis in manic-depressive disease,J. Nerv. Ment. Dis., 166: 517–520.PubMedCrossRefGoogle Scholar
  11. Lambert, P.-A., Carraz, G., Borselli, S., and Bouchardy, M., 1975, Le dipropylacétamide dans le traitement de la psychose maniac-dépressive,L’Encephale, I: 25–31.Google Scholar
  12. Lasoń, W., Przewlocka, B., and Przewlocki, R., 1983, The effect of gamma-hydroxy-butyrate and anticonvulsants on opioid peptide content in the rat brain.Life Sci (in press).Google Scholar
  13. Lorr, M., Klett, C., McNair, D.M., and Lasky, J.J., 1962, Inpatient Multidimensional Psychiatric Scale. Consulting Psychologists Press, Palo Alto,Calif.Google Scholar
  14. Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A., and Watanabe, M., 1979, Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study,Psychopharmacology, 66: 211–217.PubMedCrossRefGoogle Scholar
  15. Post, R.M., Pickar, D., Naber, D., Ballenger, J.C., Uhde, T.W., and Bunney Jr., W.E., 1981, Effect of carbamazepine on CSF opioid activity: relationship to antidepressant response, Psychiat. Res., 5: 59–66.CrossRefGoogle Scholar
  16. Potter, W.Z., Murphy, D.L., Wehr, T.A., Linnoila, M., and Goodwin F.K., 1982, Clorgyline: a new treatment for refractory rapid cycling patients?Arch. Gen. Psychiatry, 29: 505–510.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • H. M. Emrich
    • 1
  • M. Dose
    • 1
  • R. Günther
    • 1
  • D. von Zerssen
    • 1
  1. 1.Max-Planck-Institute for PsychiatryMünchen 40Germany

Personalised recommendations